These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 9540152)

  • 1. [Pulmonary tuberculosis with resistance to 4 antitubercular drugs].
    Reichlin S; Frei R; Reusser P
    Schweiz Med Wochenschr; 1998 Feb; 128(7):264-7. PubMed ID: 9540152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New drugs for tuberculosis.
    Grassi C; Peona V
    Eur Respir J Suppl; 1995 Sep; 20():714s-718s. PubMed ID: 8590571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of tuberculosis].
    Dautzenberg B
    Rev Prat; 1996 Jun; 46(11):1350-5. PubMed ID: 8794618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing.
    Laszlo A; Rahman M; Raviglione M; Bustreo F
    Int J Tuberc Lung Dis; 1997 Jun; 1(3):231-8. PubMed ID: 9432369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of multidrug-resistant tuberculosis who acquired additional resistance to ethambutol before the result of the initial drug sensitivity test was reported].
    Wakabayashi K; Yano S; Kobayashi K; Kadowaki T; Kimura M; Ishikawa S; Ikeda T
    Kekkaku; 2010 Aug; 85(8):679-82. PubMed ID: 20845688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
    Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
    Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Resistant lung tuberculosis in Berlin 1987-1993].
    Schaberg T; Gloger G; Reichert B; Mauch H; Lode H
    Pneumologie; 1996 Jan; 50(1):21-7. PubMed ID: 8774931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis susceptibility patterns, predictors of multidrug resistance, and implications for initial therapeutic regimens at a New York City hospital.
    Weltman AC; Rose DN
    Arch Intern Med; 1994 Oct; 154(19):2161-7. PubMed ID: 7944836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-resistant tuberculosis: etiology, management and prevention.
    O'Brien RJ
    Semin Respir Infect; 1994 Jun; 9(2):104-12. PubMed ID: 7973169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistance to the first line of antitubercular regimen (a preliminary report).
    Varaiya A; Gogate A
    Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
    Ratsirahonana O; Rasolofo Razanamparany V; Rasolonavalona T; Rakotonirina V; Rakotoarisaonina A; Rakotoherisoa A; Ralamboson M; Cauchoix B; Rakotondramarina D; Ramarokoto H
    Arch Inst Pasteur Madagascar; 2002; 68(1-2):44-7. PubMed ID: 12643091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Incidence of resistance and risk factors for resistance in Mycobacterium tuberculosis. A retrospective study of 1,055 patients of a specialty hospital 1984 to 1993].
    Borchardt J; Kirsten D; Jörres R; Kroeger C; Magnussen H
    Pneumologie; 1996 Jan; 50(1):28-35. PubMed ID: 8774932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Resistance and multiresistance to antitubercular drugs in Argentina and in other Latin American countries].
    de Kantor IN; Latini O; Barrera L
    Medicina (B Aires); 1998; 58(2):202-8. PubMed ID: 9706257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug resistance pattern in multidrug resistance pulmonary tuberculosis patients.
    Rao NA; Irfan M; Soomro MM; Mehfooz Z
    J Coll Physicians Surg Pak; 2010 Apr; 20(4):262-5. PubMed ID: 20392404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
    Al-Marri MR
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antitubercular chemotherapy].
    Jouveshomme S; Dautzenberg B
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S88-104. PubMed ID: 9496594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of tuberculosis].
    Eier A; Grass S
    Wien Med Wochenschr; 1994; 144(8-9):186-8. PubMed ID: 7941607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.